Product Program year 2025 Source: CMS Open Payments

Illuccix

Drug Prostate Cancer Diagnosis

NDC 74725-100-25

Open in the dashboard

General payments

$170,195

2,841 payments

Research payments

$0

0 payments

Through program year 2025, $170,195 in general payments and $0 in research payments were reported against Illuccix (Prostate Cancer Diagnosis).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2025 General $170,195 2,841

Breakdown

Who paid General payments · program year 2025
  1. Telix Pharmaceuticals $170,195 2,841 payments
Top recipients General payments · program year 2025
  1. Paul Yonover Urology · Chicago, IL $10,793 6% · 29 payments
  2. Ramji Rajendran Radiation Oncology · Elk Grove Village, IL $5,649 3% · 5 payments
  3. Umesh Oza Diagnostic Radiology · Dallas, TX $4,639 3% · 12 payments
  4. Jaideep Sohi Nuclear Radiology · Roseville, CA $4,528 3% · 22 payments
  5. John De Groot Neurology · Houston, TX $3,525 2% · 11 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Urology $55,708 34% · 661 practitioners
  2. Diagnostic Radiology Radiology $27,585 17% · 147 practitioners
  3. Radiation Oncology Radiology $18,335 11% · 130 practitioners
  4. Neurology Psychiatry & Neurology $12,017 7% · 42 practitioners
  5. Nuclear Radiology Radiology $7,929 5% · 23 practitioners

The top 5 of 65 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Illinois $23,890 14% · 40 recipients
  2. Texas $19,841 12% · 84 recipients
  3. California $18,603 11% · 192 recipients
  4. Florida $17,427 10% · 236 recipients
  5. New York $14,530 9% · 158 recipients

The top 5 of 48 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

2,841 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record